Assay
Financial-condition grades for SEC filers
Company Report · as of Oct 9, 2026
|
| Pacific Biosciences OF California, Inc.PACB · business equipment | |
|---|---|
| Grade |  Eweakest fifth of 497 graded peers; percentile 84.1, sampling error 2.2 points; lower is stronger |
| Rank | 418 of 497 |
| Profitability | C/Dpercentile 59.2 |
| Solvency | Dpercentile 62.6 |
| Growth and financing | Dpercentile 65.9 |
| Reliability | 0.91 AUCfailure model, filers with $591M to $2.67B assets; 95% interval 0.88 to 0.94; 160 events, 2020 to 2025 |
| Peer failure rate | 1.01% a yearItem 1.03 bankruptcies, same asset band, 2012 to 2025 |
| Size band | $591M to $2.67B assetstotal assets $784.1M[1] |
| Standard universe | insiderevenue above $1M and assets above $10M[1-2] |
| Warnings | none active |
| Inputs computable | 9 of 14 |
| Graded from | filings received through Feb 25, 2026226 days before the rescan; every figure keyed to the SEC receipt date |
| Last close | $2.302026-10-08; market equity $714.9M; iex feed |
| Price used in grade | None |
| Share price, twelve months to the rescansplit-adjusted close; a lollipop at every rescan carries the letter held then; baseline ticks are SEC receipt dates of the inputs; ranges and dragging scroll the full history | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Percentile at every rescan on file, Jan 21, 2012 to Oct 9, 2026; stronger toward the top. Hover for the date. Open this report as it stood on | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Each date opens the report as it stood on that rescan. |
Business, in the company's words. Opening of Item 1 of the 10-K received Feb 25, 2026; the document on sec.gov.
We are a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. Our products and technology, which include our HiFi long-read sequencing technology, address a broad set of applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications.
The Fourteen Inputs [top]
Lower percentile is stronger. Source numbers open the SEC filing; a range that spans filings opens the sources table.
| Input | Percentile, 0 to 100 | Value | Source | Peer median | Percentile | Peers | Period end |
|---|---|---|---|---|---|---|---|
| Profitability, sleeve percentile 59.2 | |||||||
| Gross profitability | 5.8% | [1,3] | 28.5% | 86.5 | 558 | 2025-12-31 | |
| Return on invested capital | not computable | 10.9% | |||||
| prior invested-capital observation is 731 days earlier | |||||||
| Accruals ratio | (42.6%) | [1,4-6] | (7.4%) | 7.9 | 621 | 2025-12-31 | |
| Gross margin stability, five years | 7.9 pts | [2-3,7-14] | 2.4 pts | 83.2 | 429 | 2025-12-31 | |
| Solvency, sleeve percentile 62.6 | |||||||
| Twelve-month failure probability | 0.41% | 0.05% | 88.0 | 101 | 2026-06-30 | ||
| Altman Z double-prime | (13.42) | [1,15-20] | 2.18 | 84.1 | 566 | 2025-12-31 | |
| Net debt to EBITDA | not computable | 1.11x | |||||
| EBITDA must exceed $100,000 | |||||||
| Interest coverage | not computable | 3.77x | |||||
| latest aligned inputs end 2023-12-31; latest annual assets end 2025-12-31 | |||||||
| Current ratio | 5.15x | [15-16] | 2.02x | 15.6 | 666 | 2025-12-31 | |
| Growth and financing, sleeve percentile 65.9 | |||||||
| Revenue growth, three-year compound | 7.6% | [2,8,10,12] | 6.4% | 45.6 | 538 | 2025-12-31 | |
| Free cash flow growth, three-year compound | not computable | 17.2% | |||||
| current FCF must be positive and base FCF must exceed $100,000 | |||||||
| Reinvestment rate | not computable | 14.3% | |||||
| pretax income must exceed the validity floor and imply a 0%-100% tax rate | |||||||
| Asset growth, three years | (23.7%) | [1,6,21-22] | 5.0% | 93.8 | 563 | 2025-12-31 | |
| Net share issuance, one year | 1.4% | [23-24] | 0.5% | 58.4 | 407 | 2026-01-31 | |
Gross profitability. Revenue less cost of goods sold, over total assets.
Accruals ratio. Net income less operating cash flow, over average assets; lower is stronger.
Gross margin stability, five years. Standard deviation of gross margin; lower is stronger.
Twelve-month failure probability. CHS model; lower is stronger.
Net debt to EBITDA. Lower is stronger.
Net share issuance, one year. Split-adjusted; lower is stronger.
Sleeves are equal-weighted; within a sleeve each computable input carries equal weight. Composite 0.275; sampling error 2.2 percentile points on 497 peers.
Among 497 Peers [top]
Composite score of every graded peer, smoothed. Vertical rules are the letter band edges at the 20th, 40th, 60th and 80th percentiles. Small dots are the six largest peers by market equity.
| Rank | Company | Percentile | Letter | Warnings |
|---|---|---|---|---|
| 413 | ONE Stop Systems, Inc. (OSS) ONE Stop Systems, Inc. (OSS) Eweakest fifth; percentile 83.1 Nasdaq · Electronic Computers market equity $190.8M; last close $7.64 No active warnings; 9 of 14 inputs | 83.1 | E | |
| 414 | Synaptics Inc. (SYNA) Synaptics Inc. (SYNA) Eweakest fifth; percentile 83.3 Nasdaq · Semiconductors & Related Devices market equity $4.7B; last close $119.15 No active warnings; 10 of 14 inputs | 83.3 | E | |
| 415 | Comtech Telecommunications Corp. (CMTL) Comtech Telecommunications Corp. (CMTL) Eweakest fifth; percentile 83.5 Nasdaq · Radio & Tv Broadcasting & Communications Equipment market equity $35.4M; last close $1.19 Warnings: late filer; 8 of 14 inputs | 83.5 | E | late filer |
| 416 | Vontier Corp. (VNT) Vontier Corp. (VNT) Eweakest fifth; percentile 83.7 NYSE · Totalizing Fluid Meters & Counting Devices market equity $4.4B; last close $32.20 No active warnings; 8 of 14 inputs | 83.7 | E | |
| 417 | Magnite, Inc. (MGNI) Magnite, Inc. (MGNI) Eweakest fifth; percentile 83.9 Nasdaq · Services-Computer Programming, Data Processing, Etc. market equity $3.7B; last close $25.45 No active warnings; 10 of 14 inputs | 83.9 | E | |
| 418 | Pacific Biosciences OF California, Inc. (PACB) Pacific Biosciences OF California, Inc. (PACB) Eweakest fifth; percentile 84.1 Nasdaq · Laboratory Analytical Instruments market equity $714.9M; last close $2.30 No active warnings; 9 of 14 inputs | 84.1 | E | |
| 419 | Marqeta, Inc. (MQ) Marqeta, Inc. (MQ) Eweakest fifth; percentile 84.3 Nasdaq · Services-Prepackaged Software last close $17.45 No active warnings; 7 of 14 inputs | 84.3 | E | |
| 420 | Neonode Inc. (NEON) Neonode Inc. (NEON) Eweakest fifth; percentile 84.5 Nasdaq · Electronic Components, NEC market equity $14.8M; last close $0.90 No active warnings; 8 of 14 inputs | 84.5 | E | |
| 421 | Vistance Networks, Inc. (VISN) Vistance Networks, Inc. (VISN) Eweakest fifth; percentile 84.7 Nasdaq · Radio & Tv Broadcasting & Communications Equipment market equity $1.4B; last close $6.03 No active warnings; 9 of 14 inputs | 84.7 | E | |
| 422 | Methode Electronics Inc. (MEI) Methode Electronics Inc. (MEI) Eweakest fifth; percentile 84.9 NYSE · Electronic Connectors market equity $543.6M; last close $15.26 No active warnings; 10 of 14 inputs | 84.9 | E | |
| 423 | Socket Mobile, Inc. (SCKT) Socket Mobile, Inc. (SCKT) Eweakest fifth; percentile 85.1 Nasdaq · Electronic Computers market equity $5.2M; last close $0.63 Warnings: fortress balance sheet; 8 of 14 inputs | 85.1 | E | fortress balance sheet |
| Peer policy | Letter | Percentile | Peers |
|---|---|---|---|
| all graded filers, equal sleeves | E | 81.6 | 2204 |
| sector peers, equal sleeves (the grade) | E | 84.1 | 497 |
| same exchange, equal sleeves | D | 78.3 | 1219 |
| sector peers, equal inputs | E | 84.1 | 497 |
Each letter is one fifth of the 497 graded peers, about 99 companies. A boundary letter (A/B, B/C, C/D, D/E) marks a percentile within one sampling error of a band edge.
What the Price Implies [top]
Market measures at the 2026-10-08 close. None enters the grade. Percentile among graded peers with the same measure.
| Measure | Value | Peer median | Percentile | Reading |
|---|---|---|---|---|
| Twelve-month price change, skipping the latest month | 5.9% | 2.2% | 53 | hotter than 53 of 100 peers |
| Distance from 52-week high | (19.9%) | (30.0%) | 66 | closer to its high than 66 of 100 peers |
| EBIT to enterprise value | (35.7%) | 1.5% | 10 | pricier than 90 of 100 peers |
| Free cash flow yield | (15.9%) | 2.7% | 13 | pricier than 87 of 100 peers |
| Book value to price | (0.05) | 0.23 | 5 | pricier than 95 of 100 peers |
| Sales to price | 0.22 | 0.30 | 41 | pricier than 59 of 100 peers |
| Composite equity issuance, five years | 47.6% | 3.9% | 86 | more equity-funded than 86 of 100 peers |
| Relative strength against the sector, log excess return | (0.23) | (0.26) | 53 | ahead of 53 of 100 peers |
Inputs: market equity $714.9M; EBIT -$553.9M; free cash flow -$113.9M; book equity -$33.2M; sales $160.0M; debt $896.8M; cash $61.0M[25].
Diagnostics [top]
Diagnostics do not feed the grade.
| Piotroski F-score: None of 9, period end 2025-12-31 | ||
|---|---|---|
| Return on assets above zero | (43.3%) | ✗ fail[4,6] |
| Operating cash flow above zero | -$111.2M | ✗ fail[5] |
| Return on assets improved | (25.6 pts) | ✗ fail[4,6,21,26] |
| Operating cash flow exceeds net income | $435.2M | ✓ pass[4-5] |
| Long-term leverage fell | n/a[1,6,21] | |
| Current ratio improved | (232.7 pts) | ✗ fail[15-16,27-28] |
| No new shares issued | 1.4% | ✗ fail[23-24] |
| Gross margin improved | 4.4 pts | ✓ pass[2-3,7-8] |
| Asset turnover improved | 3.9 pts | ✓ pass[2,6,8,21] |
Downloads [top]
|
Sources [top]
Every citation on this page. Filing opens the SEC index page for that submission; viewer opens the SEC interactive data for the same filing; series opens the SEC XBRL API record for that tag and company.
| # | Concept | XBRL tag | Value | Period end | Received | Form | Links |
|---|---|---|---|---|---|---|---|
| 1 | assets | us-gaap:Assets | $784.1M | 2025-12-31 | 2026-02-25 | 10-K | filing · viewer · series |
| 2 | revenue | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax | $160.0M | 2025-12-31 | 2026-02-25 | 10-K | filing · viewer · series |
| 3 | gross profit | us-gaap:GrossProfit | $45.8M | 2025-12-31 | 2026-02-25 | 10-K | filing · viewer · series |
| 4 | net income | us-gaap:NetIncomeLoss | -$546.4M | 2025-12-31 | 2026-02-25 | 10-K | filing · viewer · series |
| 5 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | -$111.2M | 2025-12-31 | 2026-02-25 | 10-K | filing · viewer · series |
| 6 | assets | us-gaap:Assets | $1.3B | 2024-12-31 | 2026-02-25 | 10-K | filing · viewer · series |
| 7 | gross profit | us-gaap:GrossProfit | $37.3M | 2024-12-31 | 2026-02-25 | 10-K | filing · viewer · series |
| 8 | revenue | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax | $154.0M | 2024-12-31 | 2026-02-25 | 10-K | filing · viewer · series |
| 9 | gross profit | us-gaap:GrossProfit | $52.8M | 2023-12-31 | 2026-02-25 | 10-K | filing · viewer · series |
| 10 | revenue | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax | $200.5M | 2023-12-31 | 2026-02-25 | 10-K | filing · viewer · series |
| 11 | gross profit | us-gaap:GrossProfit | $49.0M | 2022-12-31 | 2025-03-17 | 10-K | filing · viewer · series |
| 12 | revenue | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax | $128.3M | 2022-12-31 | 2025-03-17 | 10-K | filing · viewer · series |
| 13 | gross profit | us-gaap:GrossProfit | $58.9M | 2021-12-31 | 2024-02-28 | 10-K | filing · viewer · series |
| 14 | revenue | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax | $130.5M | 2021-12-31 | 2024-02-28 | 10-K | filing · viewer · series |
| 15 | current assets | us-gaap:AssetsCurrent | $375.1M | 2025-12-31 | 2026-02-25 | 10-K | filing · viewer · series |
| 16 | current liabilities | us-gaap:LiabilitiesCurrent | $72.8M | 2025-12-31 | 2026-02-25 | 10-K | filing · viewer · series |
| 17 | retained earnings | us-gaap:RetainedEarningsAccumulatedDeficit | -$2.7B | 2025-12-31 | 2026-02-25 | 10-K | filing · viewer · series |
| 18 | operating income | us-gaap:OperatingIncomeLoss | -$553.9M | 2025-12-31 | 2026-02-25 | 10-K | filing · viewer · series |
| 19 | book equity | us-gaap:StockholdersEquity | $5.3M | 2025-12-31 | 2026-02-25 | 10-K | filing · viewer · series |
| 20 | liabilities | us-gaap:Liabilities | $778.7M | 2025-12-31 | 2026-02-25 | 10-K | filing · viewer · series |
| 21 | assets | us-gaap:Assets | $1.7B | 2023-12-31 | 2025-03-17 | 10-K | filing · viewer · series |
| 22 | assets | us-gaap:Assets | $1.8B | 2022-12-31 | 2024-02-28 | 10-K | filing · viewer · series |
| 23 | shares outstanding | dei:EntityCommonStockSharesOutstanding | 301,998,292 | 2026-01-31 | 2026-02-25 | 10-K | filing · viewer · series |
| 24 | shares outstanding | dei:EntityCommonStockSharesOutstanding | 297,852,228 | 2025-02-28 | 2025-03-17 | 10-K | filing · viewer · series |
| 25 | shares outstanding | dei:EntityCommonStockSharesOutstanding | 310,830,759 | 2026-07-31 | 2026-08-06 | 10-Q | filing · viewer · series |
| 26 | net income | us-gaap:NetIncomeLoss | -$309.9M | 2024-12-31 | 2026-02-25 | 10-K | filing · viewer · series |
| 27 | current assets | us-gaap:AssetsCurrent | $495.7M | 2024-12-31 | 2026-02-25 | 10-K | filing · viewer · series |
| 28 | current liabilities | us-gaap:LiabilitiesCurrent | $66.3M | 2024-12-31 | 2026-02-25 | 10-K | filing · viewer · series |
| 29 | cash | us-gaap:CashAndCashEquivalentsAtCarryingValue | $61.0M | 2026-06-30 | 2026-08-06 | 10-Q | filing · viewer · series |
| 30 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | -$80.3M | 2026-06-30 | 2026-08-06 | 10-Q | filing · viewer · series |
| 31 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | -$44.7M | 2026-03-31 | 2026-05-08 | 10-Q | filing · viewer · series |
| 32 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | -$92.1M | 2025-09-30 | 2025-11-06 | 10-Q | filing · viewer · series |
| 33 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | -$73.4M | 2025-06-30 | 2026-08-06 | 10-Q | filing · viewer · series |
Limitations [top]
Grade boundary. Percentile 84.1 is 4.1 points from the nearest band edge; sampling error is 2.2 points.
Peer group. Sector assignment from four-digit SIC codes, hand-tuned and published. The grade under three alternative peer policies is tabled above.
Size. Within a sector the letter tracks size. Among graded filers in the smallest asset band, 72% grade E and 0% grade A; in the largest, 13% grade E and 21% grade A. Universe as of Oct 9, 2026.
Failure model. filings 2012-01-01 to 2019-12-31 fit, filings 2020-01-01 to 2025-12-31 test; status post hoc pending confirmation. pre-registered on 2026 filings once their 12-month outcome windows close; supported if the paired per-quintile gain over the pooled model has a lower bound above 0.05.
Input validity. Revenue or total assets at or below $100,000 sets the degenerate-inputs flag. An input whose denominator is at or below $100,000 is left not computable rather than ranked.
Returns. No input on this page has a post-2015 confidence interval on returns that excludes zero. The grade ranks reported financial condition and is not a return forecast.
.jpg){kind=link}
.jpg){kind=link}
.jpg){kind=link}
.jpg){kind=link}
.jpg){kind=link}
.jpg){kind=link}
